MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Cutera Total Current Liabilities 2011-2026 | CUTR
Annual Total Current Liabilities Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.7 M | 106 M | 73.9 M | 54.4 M | 58.6 M | 47.6 M | 43.3 M | 28.4 M | 24.4 M | 23 M | 18.6 M | 18.2 M | 17 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 106 M | 17 M | 46.2 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 13.94 | -0.71 % | $ 2.09 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.4 M | $ 14.09 | -7.06 % | $ 381 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 31.87 | 2.07 % | $ 1.47 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
219 M | $ 7.0 | 5.74 % | $ 503 M |  Israel |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 4.38 | -4.58 % | $ 163 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Electromed
ELMD
|
10.5 M | $ 24.18 | 1.09 % | $ 204 M | USA |
 |
Aziyo Biologics
AZYO
|
43 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
12.7 M | $ 3.49 | 2.05 % | $ 121 M | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
468 M | $ 275.33 | 2.19 % | $ 7.77 B | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 40.88 | 2.48 % | $ 6.09 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 75.65 | 2.97 % | $ 112 B | USA |
 |
InMode Ltd.
INMD
|
70.7 M | $ 14.0 | 0.29 % | $ 905 M | Israel |
 |
IRIDEX Corporation
IRIX
|
13 M | $ 1.47 | -2.0 % | $ 23.7 M | USA |
 |
IRadimed Corporation
IRMD
|
8.51 M | $ 102.4 | 1.89 % | $ 1.3 B | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 45.89 | -0.18 % | $ 1.42 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 71.26 | 1.38 % | $ 3.89 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Medtronic PLC
MDT
|
12.9 B | $ 97.22 | 0.58 % | $ 125 B | USA |
 |
Delcath Systems
DCTH
|
6.14 M | $ 9.11 | -10.77 % | $ 260 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.48 | 1.02 % | $ 146 M | Israel |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
68.3 M | $ 77.41 | -1.12 % | $ 2.18 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
680 M | $ 251.74 | 1.46 % | $ 17.7 B | USA |
 |
Quanterix Corporation
QTRX
|
38.5 M | $ 6.7 | 6.52 % | $ 252 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.53 | -0.3 % | $ 121 M | USA |
 |
Sintx Technologies
SINT
|
2.91 M | $ 2.89 | -1.87 % | $ 10.8 M | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 4.97 | -5.78 % | $ 735 M | USA |